CD274 and head and neck squamous cell carcinoma: Moreover, pembrolizumab monotherapy was found superior to the conventional first‐line cetuximab‐chemotherapy combination in R/M HNSCC patients who are PD‐L1 positive, and regardless of PD‐L1 expression when combined with platinum‐containing treatment and fluorouracil [123].